Top AI Companies (7,011)

Strong Revenue Growth: Revenue is characterized by rapid expansion following the 2023 pivot to software, with multiple references to multi-fold growth in 2024 and continued scaling efforts into 2025. This pattern is presented alongside claims of outsized year-over-year increases tied to licensing its platform to providers.

Investor Backing & Capital Strength: A $10M Series A led by F-Prime with participation from Y Combinator, Pear VC, and Lightbank provides fresh capital to fund product development and team expansion. The timing of the raise after the reported acceleration signals investor confidence in scaling the business.

Market Expansion: Customer references now include large providers such as Cityblock Health, GrandCare, Baylor Scott & White Health, and Imagine Pediatrics. The company’s shift to licensing its platform and active hiring across functions suggest efforts to broaden market reach.

Strong Revenue Growth: Revenue is consistently rising at double-digit rates, including about 26% growth in 2025 and 22%–28% year-over-year gains across early 2026. Company disclosures also highlight increasing payers and monetization, reinforcing the revenue trajectory.

Market Expansion: International rollout accelerated across Europe and Latin America in 2025–2026, with entries into additional countries and leadership in downloads across several expansion markets. European expansion-market revenue rose sharply year over year, evidencing traction beyond core English-speaking geographies.

Strong Market Position & Advantage: The app maintains a top-tier standing among dating platforms, including #1 download positions in select European markets and a top-three rank in the U.S. Consistent MAU and payer growth alongside high download ranks indicate strengthening competitive footing.

Strong Revenue Growth: ARR is described as rising from roughly $100M in early 2024 to about $340M by early 2026, with continued momentum into 2026. This trajectory is reinforced by reports of substantial run‑rate increases alongside expanding platform usage.

Investor Backing & Capital Strength: A $300M Series F at a $9.3B valuation—reported as oversubscribed and a marked step‑up from 2024—signals strong access to capital. Co‑lead participation by Accel and GIC underscores depth of investor demand.

Innovation-Driven Growth: AI offerings such as v0 are portrayed as rapidly scaling, with millions of users and a significant share of deployments initiated by coding agents. Platform metrics like daily deployments and AI Gateway usage indicate innovation is driving adoption and workload growth.

Product Line Growth: Growth in medicines such as Eliquis, Padcev, the Vyndaqel family, Lorbrena, Nurtec/Vydura and oncology biosimilars more than offset part of the COVID-related decline in the first half of 2026. Launched and acquired products also delivered strong double‑digit operational gains in Q2 2026.

Resilient & Sustainable Growth: Underlying revenue excluding COVID products advanced at a mid‑single‑digit pace in 2025 and the first half of 2026, while total revenue returned to modest year‑over‑year growth in early 2026. Management raised the midpoint of 2026 revenue guidance, signaling improving momentum beneath headline totals.

Future-Ready Strategy: Heavy investment in a broad late‑stage pipeline and plans for numerous pivotal study starts in 2026 support longer‑term growth. Continued business development and integration of acquired assets are positioned to offset COVID normalization and loss‑of‑exclusivity pressures over time.

Profitability: Feedback suggests GAAP operating income turned positive in FY2026 and profitability has continued across recent quarters, indicating stronger earnings discipline.

Healthy Cash Flow: Feedback suggests free cash flow reached roughly $100M+ in FY2026 and remained solid in subsequent quarters, signaling improved cash generation.

Cost & Operational Efficiency: Feedback suggests margin expansion and restructuring efforts have driven better operating efficiency even as top-line growth slowed.

Strong Revenue Growth: Revenue is portrayed as rising over recent years, with directional estimates indicating 2023–24 gains and Polish filings showing long‑term expansion, albeit not strictly linear. This points to continued top‑line momentum even as exact consolidated figures remain private.

Market Expansion: Operations are described across 90+ markets with 4,000+ campaigns and ongoing hiring in multiple regions, and the company states its global expansion is still gathering pace. Geographic references include teams and roles spanning the U.S., Korea, Romania, Poland and other markets.

Product Line Growth: A self‑service platform (rtb.com) launched in 2026 targets SMBs and agencies, expanding beyond the traditional enterprise focus. Offerings are also characterized as extending into DSP, CTV/OTT, first‑party advertising, and AI/Deep Learning.

Strong Revenue Growth: Revenue is rising at around 30% year over year across recent quarters and fiscal periods, indicating continued expansion at scale. Growth is not primarily a currency effect and has been maintained across multiple updates.

Profitability: GAAP profitability has been achieved for multiple consecutive quarters, with operating income turning positive versus a loss a year earlier. Margin expansion and improved free cash flow underscore operating leverage.

Resilient & Sustainable Growth: Growth has been sustained at roughly the same pace across recent quarters and the prior fiscal year rather than spiking in a single period. Large-customer momentum and multi-product adoption underpin this consistency.

Strong Revenue Growth: Reported year-over-year growth above 500% indicates rapid scaling. Momentum is reinforced by surpassing $1B in annualized gross payment volume within roughly 10 months of launch.

Investor Backing & Capital Strength: A $20M Series A led by VMG Partners, following a prior $10M seed, signals stepped-up capital support. The company states the funding will fuel product development and expansion of engineering and go-to-market teams.

Market Expansion: Hiring plans and job listings point to nationwide scaling of installations and sales. Company materials describe active scaling across the U.S. following the Series A.

Strong Revenue Growth: Company reports indicate FY2026 orders and revenue doubled year over year. Management projections point to revenue well above $500 million for 2026, signaling rapid topline acceleration.

Investor Backing & Capital Strength: Recent financings include a $1.5 billion Series G and $500 million in preferred equity at a $12.7 billion valuation. These steps indicate substantial capital access and confidence from major financial backers.

Market Expansion: Program momentum includes a U.S. Air Force production award for CCA autonomy and a U.S. Navy ISR vehicle with a high task‑order ceiling. International traction spans India, Greece, Poland, and Taiwan, alongside plans for regional offices.

Strong Market Position & Advantage: Scale of 290M+ learners and 12k–18k enterprise customers following the May 2026 combination signals a top-tier position in online learning. The combined platform also cites 95,000 creators and more than $1.5B of 2025 revenue, reinforcing competitive heft.

Strong Revenue Growth: Coursera delivered 9% revenue growth in 2025 and, after the Udemy combination, reported Q2 2026 revenue rose about 60% year over year. Management also raised full‑year 2026 reported revenue guidance to $1.220–$1.245 billion.

Diversified Revenue Streams: Multiple engines—consumer, enterprise, and subscriptions—are contributing, with Coursera’s consumer (+10%) and enterprise (+7%) segments growing in 2025. Udemy’s subscriptions (+8%) and Udemy Business revenue (+6%) expanded even as its consumer marketplace declined.

Market Expansion: Patient reach rose from 22M in 2022 to 25M in 2023 and 50M by January 2025, alongside new wins such as Sanford Health and multiple physician groups adopting the platform. Kora was also adopted by 10 provider organizations within its first year, reinforcing broader commercial uptake.

Product Line Growth: Cedar expanded from payments/billing into affordability, AI support, and the Kora AI agent in 2025–26, later broadening into the multi‑agent Kora Platform. Additional launches like Cedar Cover extended capabilities into Medicaid enrollment, renewals, and denials resolution.

Innovation-Driven Growth: AI‑driven workflows are central, with Kora handling roughly 400,000 patient calls in its first year and continued rollout of Cedar Intelligence in 2026. Recognition and ongoing AI feature releases signal a strategy centered on technology-led growth in healthcare financial workflows.

Profitability: GAAP net income turned positive in Q1 and Q2 2026 and non‑GAAP operating margin improved year over year, indicating meaningful bottom‑line progress. Adjusted EBITDA also increased, supporting a trend toward sustainable earnings.

Cost & Operational Efficiency: A September 2026 operating plan targets approximately $60M–$80M in annualized cost savings and raised operating income guidance, reflecting disciplined execution. Positive operating cash flow and sequential margin gains point to improving operational leverage.

Future-Ready Strategy: Product moves highlight AI- and agentic‑commerce capabilities and payments initiatives (e.g., BigCommerce Payments by PayPal) across BigCommerce, Feedonomics, and Makeswift. This orientation suggests readiness to better monetize growing GMV and new channels.

Investor Backing & Capital Strength: SoftBank ownership and subsequent capital deployments are described as materially strengthening the company’s funding base, with multiple 2025–26 share allotments and later injections supporting expansion. Evidence indicates this provides far greater financial backing than before the acquisition.

Strong Hiring & Retention: Plans to double UK headcount to around 750 and create 500 semiconductor roles in India signal substantial workforce expansion. The company also indicated immediate hiring of 100 India engineering roles, suggesting growth already underway.

Market Expansion: Announcements of a new AI Engineering Campus in Bengaluru and additional international offices point to a broader geographic footprint. These moves indicate active scaling of R&D capacity across regions.

Market Expansion: A multi-year U.S. government enterprise agreement with a $70M ceiling and subsequent Army task orders indicate scaled access and active utilization across defense agencies. Participation in the Army’s NGC2 efforts and deployments spanning the Army, Navy, and Combatant Commands point to a widening program footprint.

Investor Backing & Capital Strength: A 2026 Series B growth investment led by Washington Harbour Partners, following a prior $33M institutional round, signals strengthened capital support. Management explicitly tied the new capital to expanding engineering, R&D, and delivery capacity.

Strong Revenue Growth: Earlier independent coverage cited very rapid ARR growth over a multi-year period and recognition among fast-growing technology companies. These signals collectively suggest meaningful historical revenue momentum even without current audited figures.

Investor Backing & Capital Strength: A $200 million Series B at a $2.2 billion valuation, following earlier rounds, provides substantial resources to scale. Company announcements link this capital directly to manufacturing expansion and accelerated deployment of Bullfrog.

Market Expansion: Operations expanded with a 191,000-square-foot manufacturing facility in Austin and a new engineering office in Silicon Valley, alongside earlier growth of the Austin headquarters. Awards with the U.S. Army and Marine Corps and reported activity with allied militaries indicate broader market reach.

Strong Hiring & Retention: Headcount has risen into the hundreds, and active requisitions span engineering, manufacturing, and operations. Hiring events and multi-disciplinary job postings signal continued workforce scaling to meet production needs.

Strong Revenue Growth: Revenue and ARR are described as increasing, including crossing a significant ARR milestone and year-over-year gains. Company disclosures and third-party profiles align on continued scaling of recurring revenue.

Market Expansion: Geographic expansion is emphasized by notable momentum in North America, with new enterprise wins and a growing local team. The region’s contribution is portrayed as increasingly meaningful alongside broader international reach.

Investor Backing & Capital Strength: Substantial total funding and a large late-stage round provide resources for hiring, acquisitions, and R&D. This capital base is cited as enabling continued scale-up and product investment.

Strong Revenue Growth: ARR is reported to have exceeded $600M by late 2025 and continued upward into 2026, indicating substantial monetization progress. Directionally rising figures from 2020–2026 support a clear upward trajectory despite private-company reporting limits.

Market Expansion: User scale reportedly surpassed 100M by 2024 with more than half of the Fortune 500 using the product and a large international user mix, pointing to expanding geographic and enterprise reach. An increasing share of paying customers and deeper enterprise penetration reinforce breadth beyond individual users.

Innovation-Driven Growth: AI capabilities—ranging from Notion AI to autonomous agents—are described as major growth levers, with over half of ARR linked to AI-enabled customers. Product additions like agents and calendar broaden the suite and appear to lift adoption and ARPU.

Strong Market Position & Advantage: QuillBot is frequently characterized as a major player and category leader in paraphrasing/writing assistance, operating at very large scale with tens of millions of monthly visits and a self-reported 35M+ monthly active writers. It is consistently listed among top competitors alongside Grammarly in student and creator ecosystems.

Product Line Growth: The platform has expanded from paraphrasing into a broader suite—grammar checking, summarization, citation generation, plagiarism/AI detection, translation—and is described as moving into audio, image, and search tools. This widening footprint signals ongoing product expansion into adjacent use cases.

Investor Backing & Capital Strength: Being part of Learneo (formerly Course Hero) since 2021 provides corporate resources, portfolio synergies, and distribution that support scale and stability. The business is described as profitable with ARR estimates in the tens of millions, reinforcing monetization strength.

Strong Revenue Growth: Reported results show rapid top-line acceleration, including 56% growth in 2025 and year-over-year increases of 85% in Q1 2026 and 93% in Q2 2026. Management also raised full-year 2026 revenue guidance to around 82% growth, indicating continued momentum.

Profitability: Profitability is expanding, with 2025 operating income rising to about $1.41B from $310M and subsequent quarters reporting substantial GAAP profits. Operating leverage and margins increased alongside growth, per the latest quarterly results.

Diversified Revenue Streams: Growth spans both government and commercial segments, with 2025 government revenue up 53% and commercial up 60% and U.S. commercial surging triple-digits in 2026. Deal activity and total contract value also climbed, signaling multiple engines contributing to the top line.

Strong Revenue Growth: Revenue and ARR are described as growing at double-digit rates across 2023–2025, with seven consecutive years of revenue growth reported through 2023. Feedback suggests momentum came from both new customer logos and expansion ARR in existing enterprises.

Market Expansion: Geographic and customer reach is expanding, with TrakSYS reportedly deployed in thousands of factories across 140+ countries alongside new logo wins and increased bookings. Feedback suggests ongoing enterprise sales hiring and multi-site deployments are broadening coverage.

Investor Backing & Capital Strength: Capital support was bolstered by a 2023 recapitalization led by BVP Forge explicitly aimed at scaling the platform and accelerating growth. Feedback suggests this backing is enabling continued product and organizational investment.